Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

AMS:PRX - NL0013654783 - Common Stock

53.745 EUR
+0.28 (+0.53%)
Last: 9/11/2025, 12:07:49 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PRX. PRX was compared to 12 industry peers in the Broadline Retail industry. PRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PRX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make PRX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

PRX had positive earnings in the past year.
PRX had a positive operating cash flow in the past year.
In the past 5 years PRX has always been profitable.
In multiple years PRX reported negative operating cash flow during the last 5 years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

With an excellent Return On Assets value of 17.04%, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PRX has a Return On Equity of 24.23%. This is amongst the best in the industry. PRX outperforms 83.33% of its industry peers.
The Return On Invested Capital of PRX (0.21%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 200.44%, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PRX's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 3.05%, PRX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
With a Gross Margin value of 42.53%, PRX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Gross Margin of PRX has grown nicely.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

7

2. Health

2.1 Basic Checks

PRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PRX has been reduced compared to 1 year ago.
Compared to 5 years ago, PRX has more shares outstanding
The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

An Altman-Z score of 5.23 indicates that PRX is not in any danger for bankruptcy at the moment.
PRX has a Altman-Z score of 5.23. This is in the better half of the industry: PRX outperforms 66.67% of its industry peers.
The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.30, PRX is in line with its industry, outperforming 41.67% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that PRX is not too dependend on debt financing.
The Debt to Equity ratio of PRX (0.30) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 5.23
ROIC/WACC0.03
WACC7.16%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

PRX has a Current Ratio of 3.54. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
PRX's Current ratio of 3.54 is amongst the best of the industry. PRX outperforms 100.00% of its industry peers.
A Quick Ratio of 3.50 indicates that PRX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.50, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.26% over the past year.
Measured over the past years, PRX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.24% on average per year.
PRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.86%.
The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

PRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.50% yearly.
PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.47% yearly.
EPS Next Y25.84%
EPS Next 2Y19.96%
EPS Next 3Y16.5%
EPS Next 5YN/A
Revenue Next Year24.08%
Revenue Next 2Y16.97%
Revenue Next 3Y14.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

PRX is valuated correctly with a Price/Earnings ratio of 12.16.
Based on the Price/Earnings ratio, PRX is valued cheaper than 100.00% of the companies in the same industry.
PRX is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.22, which indicates a correct valuation of PRX.
Based on the Price/Forward Earnings ratio, PRX is valued a bit cheaper than 75.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.54. PRX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.16
Fwd PE 15.22
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRX is valued a bit more expensive than 75.00% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PRX.
Industry RankSector Rank
P/FCF 84.71
EV/EBITDA 402.25
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRX's earnings are expected to grow with 16.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.47
PEG (5Y)0.71
EPS Next 2Y19.96%
EPS Next 3Y16.5%

More info and screens

3

5. Dividend

5.1 Amount

PRX has a yearly dividend return of 0.19%, which is pretty low.
PRX's Dividend Yield is a higher than the industry average which is at 1.20.
Compared to an average S&P500 Dividend Yield of 2.45, PRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PRX pays out 2.17% of its income as dividend. This is a sustainable payout ratio.
DP2.17%
EPS Next 2Y19.96%
EPS Next 3Y16.5%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

PROSUS NV

AMS:PRX (9/11/2025, 12:07:49 PM)

53.745

+0.28 (+0.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)06-23 2025-06-23/amc
Earnings (Next)11-24 2025-11-24
Inst Owners63.56%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap127.86B
Analysts76.52
Price Target57.76 (7.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.13%
PT rev (3m)7.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.44%
EPS NY rev (3m)4.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)10.53%
Valuation
Industry RankSector Rank
PE 12.16
Fwd PE 15.22
P/S 24.26
P/FCF 84.71
P/OCF 79.92
P/B 2.93
P/tB 3.02
EV/EBITDA 402.25
EPS(TTM)4.42
EY8.22%
EPS(NY)3.53
Fwd EY6.57%
FCF(TTM)0.63
FCFY1.18%
OCF(TTM)0.67
OCFY1.25%
SpS2.22
BVpS18.33
TBVpS17.77
PEG (NY)0.47
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 5.23
F-Score6
WACC7.16%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y25.84%
EPS Next 2Y19.96%
EPS Next 3Y16.5%
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year24.08%
Revenue Next 2Y16.97%
Revenue Next 3Y14.47%
Revenue Next 5YN/A
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year227%
EBIT Next 3Y90.81%
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A